Search research articles
Contact Us
Filters
Showing results (151-160 of 231) with videos related to
Page
of 24
Sort By:
The Journal of Allergy and Clinical Immunology
|
August 10, 2001
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils
T Zuberbier, S U Chong, K Grunow, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer
Clemens Grassberger, Stephen Dowdell, Antony Lomax, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 18, 2026
No evidence for depletion of circulating lymphocyte populations in primary brain tumor patients receiving radiotherapy alone
Chris Beekman, Satoru Morita, Shane Neibart, et al.
Journal of Medicinal Chemistry
|
July 23, 1993
Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment
P Nussbaumer, G Dorfstätter, M A Grassberger, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo
Dieter Scholz, Karl Baumann, Max Grassberger, et al.
Physics in Medicine and Biology
|
July 17, 2014
Computing proton dose to irregularly moving targets
Justin Phillips, Gueorgui Gueorguiev, James A Shackleford, et al.
Advances in Radiation Oncology
|
August 5, 2022
Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
Susannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, et al.
Medical Physics
|
May 3, 2013
Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions
Chuan Zeng, Drosoula Giantsoudi, Clemens Grassberger, et al.
Cancer Research
|
September 10, 2020
Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction Period
David M McClatchy, Henning Willers, Aaron N Hata, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 5, 2023
Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology
Susannah G Ellsworth, Peter S N van Rossum, Radhe Mohan, et al.
Page
of 24
Search research articles
Search
Showing results (151-160 of 231) with videos related to
Sort By:
Page
of 24
The Journal of Allergy and Clinical Immunology
|
August 10, 2001
The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils
T Zuberbier, S U Chong, K Grunow, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer
Clemens Grassberger, Stephen Dowdell, Antony Lomax, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 18, 2026
No evidence for depletion of circulating lymphocyte populations in primary brain tumor patients receiving radiotherapy alone
Chris Beekman, Satoru Morita, Shane Neibart, et al.
Journal of Medicinal Chemistry
|
July 23, 1993
Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment
P Nussbaumer, G Dorfstätter, M A Grassberger, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo
Dieter Scholz, Karl Baumann, Max Grassberger, et al.
Physics in Medicine and Biology
|
July 17, 2014
Computing proton dose to irregularly moving targets
Justin Phillips, Gueorgui Gueorguiev, James A Shackleford, et al.
Advances in Radiation Oncology
|
August 5, 2022
Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
Susannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, et al.
Medical Physics
|
May 3, 2013
Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions
Chuan Zeng, Drosoula Giantsoudi, Clemens Grassberger, et al.
Cancer Research
|
September 10, 2020
Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction Period
David M McClatchy, Henning Willers, Aaron N Hata, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 5, 2023
Declarations of Independence: How Embedded Multicollinearity Errors Affect Dosimetric and Other Complex Analyses in Radiation Oncology
Susannah G Ellsworth, Peter S N van Rossum, Radhe Mohan, et al.
Page
of 24